Press Release Distribution
CUSTOM DATA FEEDS
Become a client
Publishing & Media
Traders And Investors Trend Analysis Reports: (NASDAQ: BGMD), (NASDAQ: SOMX)
New York (December 11th, 2012) - BG Medicine Inc. (NASDAQ: BGMD), a provider of drug research and development services, is seeing a huge rally in mid-day trading today after the company announced that obtained CE Mark for its CardioSCORE test in Europe. The company’s President and CEO, Eric Bouvier said that he believes the CardioSCORE test will be a pivotal and disruptive game-changer in the primary prevention of major cardiovascular events and treatment of disease, representing a major advancement over the diagnostic tools used by clinician for the past 15 years.
BGMD is currently trading 133.83% higher at $3.11 on volume of 6.54 million, which is well above the daily average volume of 274,064. BGMD has crossed its 50-day moving average as a result of today’s rally.
Find out where BGMD could be headed in the very short term here:
Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX), a specialty pharmaceutical company engaged in the in-licensing, development and commercialization of branded products and late-stage product candidates, is seeing a huge rally in trading today after the company agreed to be acquired by Perninx Therapeutics.
Under the terms of the agreement, Pernix will acquire SOMX for $25 million in a stock-for-stock transaction. The transaction has been approved by the Board of Directors of both companies. At last check, SOMX was trading 76.87% higher at $2.60 on volume of 1.87 million, which is substantially above the daily average volume of 56,326. The stock hit an intra-day high of $2.92 in trading earlier today.
Find out more about SOMX here:
WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.
WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetScoop.net
Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.
BECOME A CLIENT
CONNECT WITH US
Toll Free: 888.952.4446 Opt 2
Toll Free: 888.952.4446 Opt 1
Copyright 2017 © ACCESSWIRE. All rights reserved.
Terms and Conditions
Copyright 2017 © ACCESSWIRE.
All rights reserved.
Terms and Conditions